Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer

Cancer Biology and Therapy

Volumn 1, Issue 4, 2002, Pages 362-367

  Velasco, Alfredo ^a   Albert, Paul S ^b   Rosenberg, Helmar ^a   Martinez, Carlos ^a   Leach, Fredrick S ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

hMSH2 gene expression; Microsatellite instability; Mismatch repair; Prostate cancer

Indexed keywords

DNA BINDING PROTEIN; MICROSATELLITE DNA; MSH2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN MSH2;

AGED; ARTICLE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PROSTATE TUMOR; TIME;

AGED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; TIME FACTORS;

EID: 0842301012     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.4.7     Document Type: Article

References (43)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50:7-33.
2. Dennis LK, Resnick MI. Analysis of recent trends in prostate cancer incidence and mortality. Prostate 2000; 42:247-52. (Pubitemid 30104567)
3. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281:1395-400. (Pubitemid 29190217)
4. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281:1591-7. (Pubitemid 29211767)
5. Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, et al. Racial and ethnic differences in advanced-stage prostate cancer: the prostate cancer outcomes study. JNCI 2001; 93:388-95. (Pubitemid 32229383)
6. Brawn PN, Johnson EH, Kuhl DL, Riggs MW, Speights VO, Johnson CF, et al. Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer 1993;71:2569-73. (Pubitemid 23100493)
7. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. PNAS 1992;89:3367-71.
8. Walsh PC, Partin AW. Family history facilitates the early diagnosis of prostate carcinoma. Cancer 1997; 80:1871-4. (Pubitemid 27475951)
9. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280:975-80. (Pubitemid 28445095)
10. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993; 150:797-802. (Pubitemid 23241269)
11. Woolf CM. An investigation of familial aspects of carcinoma of the prostate. Cancer 1960; 13:739-44.
12. Brawley OW. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer 1997; 80:1857-63. (Pubitemid 27475949)
13. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, et al. Cancer surveillance series: Interpreting trends in prostate cancer-part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. JNCI 1999; 91:1017-24. (Pubitemid 29293040)
14. Chodak GW, Thisted R, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. New Engl J Med 1994; 330:242-8. (Pubitemid 24034136)
15. Iversen P, Madsen PO, Corle DK. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Scand J Urol Nephrol 1995;172:65-72.
16. Paulsen DF, Lin GH, Hinshaw W et al. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate: twenty-three year follow-up of a prospective randomized study. J Urol 1982;128:502-4.
17. Wilt TJ. Uncertainty in prostate cancer care. JAMA 2000; 283:3258-60.
18. Friedrich MJ. Issues in prostate cancer screening. JAMA 1999; 281:1573-8.
19. Fowler FJ, McNaughton Collins M, Albertsen PC, Zietman A, Elliot DB, et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000; 283:3217-22. (Pubitemid 30422039)
20. D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA 2000; 284:1280-3.
21. Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol 2001; 165:1562-8. (Pubitemid 32410239)
22. Partin AW, Subong ENP, Walsh PC, et al. Combination of prostate-specific antigen clinical stage, and Gleason score to predict pathologic stage of localized prostate cancer: a multi-institutional update. JAMA 1997; 277:1445-51. (Pubitemid 27208886)
23. Fearon E, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67
24. Cussenot O, Valeri A. Heterogeneity in genetic susceptibility to prostate cancer. Eur J Int Med 2001;12:11-6. (Pubitemid 32112076)
25. Verma RS, Manikal M, Conte RA, Godec CJ. Chromosomal basis of adenocarcinoma of the prostate. Cancer Invest 1999; 17:4417.
26. Peltomaki P. DNA mismatch repair and cancer. Mutat Res 2001; 488:77-85. (Pubitemid 32166784)
27. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 1996; 65:101-33. (Pubitemid 26250606)
28. Lynch HT, Ens JA, Lynch JF. The Lynch syndrome II and urologic malignancies. J Urol 1990;143:24-8.
29. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85. (Pubitemid 23051366)
30. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260:812-6. (Pubitemid 23167611)
31. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260:816-9. (Pubitemid 23167612)
32. Ionov YM, Peinado A, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363:558-61. (Pubitemid 23186645)
33. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colon cancer. Cell 1993; 75:1215-25. (Pubitemid 24006117)
34. Leach FS, Polyak K, Burrell M, Johnson KA, Hill D, Dunlop MG, et al. Expression of the mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996; 56:235-40. (Pubitemid 26026346)
35. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56:4836-40. (Pubitemid 26374414)
36. Chen Y, Wang J, Fraig MM, Metcalf J, Turner WR, Bissada, et al. Defects of DNA mismatch repair in human prostate cancer. Cancer Res 2001; 61:4112-21. (Pubitemid 32720979)
37. Leach FS, Velasco A, Hsieh J-T, Sagalowsky AI, McConnell JD. The human mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP. J Urol 2000; 164:1830-33.
38. Boyer JC, Umar A, Risinger JI, Lipford JR, Kane M, Yin S, et al. Microsatellite instability, mismatch repair deficiency and genetic defects in human cancer cell lines. Cancer Res 1995; 55:6063-70.
39. Velasco A, Hewitt SM, Albert PS, Saboorian MH, Rosenberg H, Martinez C, et al. Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence. Cancer 2002; 94:690-9. (Pubitemid 34132297)
40. Gao X, Wu B, Grignon D, Zacharek A, Liu H, Salkowski A, et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 1994; 9:2999-3003.
41. Uchida T, Wada C, Wang C, Ishida H, Egawa S, Yokoyama E, et al. Microsatellite instability in prostate cancer. Oncogene 1995; 10:1019-22.
42. Egawa S, Uchida T, Suyama K, Wang C, Ohori M, Irie S, et al. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res 1995; 55:2418-21.
43. Rizki A, Lundblad V. Defects in mismatch repair promote telomerase-independent proliferation. Nature 2001;411713-716.